Literature DB >> 11238785

Calorie restriction in obesity: prevention of kidney disease in rodents.

J S Stern1, M D Gades, C M Wheeldon, A T Borchers.   

Abstract

The incidence of end-stage renal disease (ESRD) has risen considerably in the past two decades. This trend is partly due to the alarming rise in the incidence of type 2 diabetes over the same period, which in turn might be linked to the staggering increase in overweight and obesity. If these trends continue, ESRD can be expected not only to cause suffering of ever growing numbers of patients, but also to become an increasing financial as well as logistical burden on the health care system. Therefore, it is imperative not only to gain a better understanding of the molecular, cellular and metabolic mechanisms involved in renal pathology, but also to uncover treatment modalities, including lifestyle changes, that can help prevent and/or slow the progression of kidney pathogenesis. Insights into both of these aspects are provided by animal models of obesity and diabetes. It has long been known that food restriction, more so than restriction of any particular dietary component, can greatly enhance longevity in laboratory rodents. These findings are being extended into a variety of other mammals, including nonhuman primates. These studies have indicated that caloric restriction in nonobese laboratory animals does not primarily affect specific disease processes but rather nonspecifically slows the aging process. In contrast, a growing body of evidence suggests that in genetically obese animals, food restriction can prevent or greatly delay the onset of specific degenerative lesions, in particular glomerulonephritis associated with obesity and diabetes.

Entities:  

Mesh:

Year:  2001        PMID: 11238785     DOI: 10.1093/jn/131.3.913S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  17 in total

1.  Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction.

Authors:  G Chen; E A Bridenbaugh; A D Akintola; J M Catania; V S Vaidya; J V Bonventre; A C Dearman; H W Sampson; D C Zawieja; R C Burghardt; A R Parrish
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-01

Review 2.  Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence.

Authors:  Koji Tomobe; Yasuyuki Nomura
Journal:  Neurochem Res       Date:  2009-02-27       Impact factor: 3.996

3.  Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease.

Authors:  Lesley Gardiner; Adebayo Akintola; Gang Chen; Jeffrey M Catania; Vishal Vaidya; Robert C Burghardt; Joseph V Bonventre; Jerome Trzeciakowski; Alan R Parrish
Journal:  Am J Nephrol       Date:  2012-01-20       Impact factor: 3.754

4.  Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.

Authors:  Shankar Munusamy; Jussara M do Carmo; Jonathan P Hosler; John E Hall
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

Review 5.  Sirtuins and their relevance to the kidney.

Authors:  Chuan-Ming Hao; Volker H Haase
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

Review 6.  SIRT1 and Kidney Function.

Authors:  Yi Guan; Chuan-Ming Hao
Journal:  Kidney Dis (Basel)       Date:  2015-10-13

7.  Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes.

Authors:  Shuta Motonishi; Masaomi Nangaku; Takehiko Wada; Yu Ishimoto; Takamoto Ohse; Taiji Matsusaka; Naoto Kubota; Akira Shimizu; Takashi Kadowaki; Kazuyuki Tobe; Reiko Inagi
Journal:  J Am Soc Nephrol       Date:  2014-11-25       Impact factor: 10.121

8.  Calpain 10 is required for cell viability and is decreased in the aging kidney.

Authors:  Marisa D Covington; David D Arrington; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

9.  Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure.

Authors:  Pedro Gomes; Sónia Simão; Elisabete Silva; Vanda Pinto; João S Amaral; Joana Afonso; Maria Paula Serrão; Maria João Pinho; Patrício Soares-da-Silva
Journal:  Oxid Med Cell Longev       Date:  2009 Jul-Aug       Impact factor: 6.543

Review 10.  Impact of the obesity epidemic on hypertension and renal disease.

Authors:  John E Hall; Daniel W Jones; Jay J Kuo; Alexandre da Silva; Lakshmi S Tallam; Jiankang Liu
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.